The 340B Drug Pricing Program plays an important part in funding our mission to create a healthier Hawaii. The federal program provides eligible safety net hospitals access to discounted outpatient drugs, that helps Hawaii Pacific Health offset losses its medical centers and clinics incur when caring for our state’s most vulnerable and underserved individuals.
HPH invests in programming and community support efforts that exceed the savings it receives from the 340B program. HPH’s FY23 340B savings of $48.3 million is less than half that of its total Community Benefit activity in FY23 of $78.2 million.
The 340B Drug Pricing Program allows the financial flexibility needed to invest in tailored solutions that address the unique needs of communities we serve. Were the program to be eliminated or scaled back, the 340B-eligible medical centers in the Hawaii Pacific Health system would struggle to continue to provide much-needed health care to low-income and underinsured individuals. It also would jeopardize our long-standing, vital partnerships with those who serve isolated rural communities.